On ECHEMI
Home > Drugs > Gastrinoma
Gastrinoma
Gastrinoma, also known as Zollinger-Ellison syndrome, is a clinical syndrome characterized by refractory or unusual peptic ulcers, high gastric acid secretion, and non-β islet cell tumors. The cause of gastrinoma is unknown, but it may originate from the α1 cells of the pancreas. Since gastrinoma is more common in pancreatic tissue and less common in other tissues outside the pancreas, and the tumor is small, it is sometimes difficult to accurately locate the tumor. However, in recent years, with the improvement of B-ultrasound, CT or MRI diagnostic technology, good conditions have been created for tumor localization. If the tumor has no distant metastasis, it can be cured after tumor resection.
Related Drugs
Omeprazole enteric-coated capsules
Indication: Indicated for peptic ulcer (stomach, duodenum), reflux esophagitis and Zollinger-Ellison syndrome (gastrinoma).
Omeprazole Sodium Enteric-coated Tablets
Indication: It is suitable for gastric ulcer, duodenal ulcer, stress ulcer, reflux esophagitis and Zollinger-Ellison syndrome (gastrinoma).
Manufacturer:

Beijing Continent Pharmaceuticals Co., Ltd.

Omeprazole Sodium Enteric-coated Tablets
Indication: It is suitable for gastric ulcer, duodenal ulcer, stress ulcer, reflux esophagitis and Zollinger-Ellison syndrome (gastrinoma).
Manufacturer:

Hebei Sanjiu'aidefu Pharmaceutical Co., Ltd.

Omeprazole enteric-coated tablets
Indication: It is suitable for gastric ulcer, duodenal ulcer, stress ulcer, reflux esophagitis and Zollinger-Ellison syndrome (gastrinoma).
Famotidine injection
Indication: It is suitable for peptic ulcer (gastric and duodenal ulcer), acute gastric mucosal lesions, reflux esophagitis and gastrinoma.
Manufacturer:

Sinopharm Ronshyn Pharmaceutical Co., Ltd.

Omeprazole enteric-coated capsules
Indication: It is suitable for gastric ulcer, duodenal ulcer, stress ulcer, reflux esophagitis and Zollinger-Ellison syndrome (gastrinoma).
Manufacturer:

Jinzhou Jiutai Pharmaceutical Co., Ltd.

Cimetidine injection
Indication: This product is suitable for the treatment of clearly diagnosed duodenal ulcer and gastric ulcer; patients with recurrence of duodenal ulcer after short-term treatment; patients with persistent gastroesophageal reflux disease who are ineffective in anti-reflux measures and single drug treatment such as antacids; prevention of stress ulcers and bleeding in critically ill patients; gastrinoma (Zollinger-Ellison syndrome).
Manufacturer:

Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd.

Cimetidine injection
Indication: This product is suitable for the treatment of clearly diagnosed duodenal ulcer and gastric ulcer; patients with recurrence of duodenal ulcer after short-term treatment; patients with persistent gastroesophageal reflux disease who are ineffective in anti-reflux measures and single drug treatment such as antacids; prevention of stress ulcers and bleeding in critically ill patients; gastrinoma (Zollinger-Ellison syndrome).
Manufacturer:

Shandong FANGMING Pharmaceutical Group Co., Ltd.

Cimetidine injection
Indication: 1. Treatment of duodenal ulcer and gastric ulcer that have been clearly diagnosed. 2. Patients with recurrence of duodenal ulcer after short-term treatment. 3. Patients with persistent gastroesophageal reflux disease who are ineffective in anti-reflux measures and single drug treatment such as antacids. 4. Prevention of stress ulcer and bleeding in critically ill patients. 5. Gastrinoma (Zollinger-Ellison syndrome).
Manufacturer:

Fuzhou FU Yao Pharmaceutical Co., Ltd.

Cimetidine injection
Indication: This product is suitable for: 1. Treatment of duodenal ulcer and gastric ulcer that have been clearly diagnosed. 2. Patients with recurrence of duodenal ulcer after short-term treatment. 3. Patients with persistent gastroesophageal reflux disease, who are ineffective in anti-reflux measures and single drug treatment such as antacids. 4. Prevention of stress ulcer and bleeding in critically ill patients. 5. Gastrinoma (Zollinger-Ellison syndrome).
Manufacturer:

Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.